Notes on the International Cannabis Trade

Home | Canna Law Blog | Notes on the International Cannabis Trade Before the holiday, I had the pleasure of being invited to speak on international cannabis at The Global Business of Cannabis Conference organized by the American Bar Association International Law Section. My panel looked at the wide range of the current progress towards legalization of cannabis across North America - Canada (recreational cannabis legal since 2018), Mexico (legislation pending to legalize recreational marijuana), and Brazil (still strictly illegal, but pending legislation to consider allowing medical marijuana). We then tried to look into our crystal balls to try to see what the future of international trade of marijuana might look like in the hopefully not too distant future. At this point there is little to no international trade of legal cannabis. In the U.S., it is still illegal for marijuana to cross state borders, let alone national borders. Even between countries where cannabis is legal, the international trade is limited to medical and scientific purposes and subject to extensive regulatory and licensing requirements from both importing and exporting countries. No one realistically expects fully free international trade of legal cannabis to happen any time in the near future. But the continuing trend towards legalization of cannabis in so many countries suggests that the potential for international trade of cannabis is a realistic achievable goal and not just a pipe dream. Many folks working towards expanding the legalization of cannabis will focus on the potential benefits and opportunities that international trade will create for the cannabis industry. Within the framework of the US-Mexico-Canada Agreement (NAFTA 2.0), we have written about the possibility of a super North American cannabis industry that maximizes the advantages that each country offers. Canada with its full legalization has a clear head start at developing financing, distributional and operational infrastructure. Mexico has better growing environment for marijuana and lower farm labor rates that could provide significant cost advantages. The U.S. at a minimum offers the sheer size of its market. Companies who can access and fully utilize these advantages from trade across all three North American countries would have a clear competitive advantage. However, it is also important to consider the potential risks of what can happen when legal cannabis products are finally allowed to be traded across international borders. While some will welcome imports, others will complain that imports are unfairly driving prices so low that they can no longer compete in the market anymore. International trade often creates at least the perception of “winners” and “losers” of import competition. Often a domestic industry that feels it is “losing” to imports resorts to filing legal actions based on international trade laws designed to protect domestic industries against the injury they are suffering from unfairly traded imports that are either sold at unfairly low prices (dumping), or are unfairly subsidized by the foreign government (countervailing duties). China is often viewed as a primary source of unfair trade for products ranging from various chemicals, to kegs to crawfish. But even just within agricultural products, there have been many antidumping and countervailing duty (AD/CVD) cases filed against Canada (lumber, wheat, cattle) and Mexico (tomatoes, sugar). All these cases are warning signs for those people planning on making international trade of cannabis happen. Those people should also consider how trade disputes can throw a huge monkey wrench into those plans. If (or when) the federal government allows foreign cannabis to be imported into the United States, it is not hard to imagine that US growers who invested so much in setting up their own cannabis operations may feel threatened by the influx of bigger or better financed Canadian producers or lower cost Mexican cannabis imports cutting into their market share. And don’t forget about China as a potential low cost source of cannabis imports. Right now China is not a player in the cannabis market, but China is already the world’s leader in hemp production. So China could become a huge force in the cannabis market if they ever decide to get into the international trade of cannabis. If imports are allowed to rush into the U.S. market, it would not be surprising to see some U.S. producers consider using U.S. trade laws to try to fend off the damaging effects caused by imports. Another interesting factor on the potential development of international trade of legal cannabis is the significant market presence of illicit marijuana. After Canada legalized recreational marijuana in 2018, spending on illicit cannabis products in Canada has declined steadily while sales through legal cannabis distributors increased. In third quarter 2020, legal recreational cannabis spending in Canada for the first time surpassed the amount spent on illicit cannabis. The legal cannabis market has grown because of the increase in openings of legal regulated stores that can offer a wider range of products and consistent inventory than many illicit cannabis sellers. Also the price for legal cannabis has dropped significantly so that it is relatively close to the price of illicit cannabis. If the difference in price is not too significant, many consumers prefer buying legal rather than illegal marijuana. Dealers of illicit marijuana could benefit from antidumping duties or other trade actions that would artificially increase the market price for legal cannabis, which could create a more significant price gap between legal and illegal cannabis. With antidumping duties supporting a higher legal cannabis price, this could make illegal cannabis to be a more attractive lower priced alternative for certain consumers. Or antidumping duties could also allow the price of illegal cannabis to also increase, at least proportional to the increase in legal cannabis prices The trade battles with cannabis are still a way off. But in the immediate near term future, it may be worth keeping an eye on products such as hemp and CBD that are in the cannabis space and trade is already starting to happen. For example, it is possible a case could be brought on a narrowly defined product such as hemp biomass. When hemp was legalized with the 2018 Farm Bill, many farmers across America rushed in to plant hemp. Not surprisingly, the supply of hemp soon exceeded demand as there simply were not enough hemp buyers or processors of hemp that were available to soak up all that hemp supply. If the volume of imported hemp biomass is significant or the prices are significantly lower than domestic hemp biomass, these could be indicators of a possible antidumping case just waiting to be filed. So, as international trade of cannabis gets closer to a reality, it will become important for companies in the cannabis industry to better understand how U.S. trade laws can be used by domestic producers to try to protect their US market position against import competition. Similarly, US importers and foreign producers and exporters may soon need to understand how AD/CVD cases can disrupt any plans to export to the US market and what options they may have to respond to such actions. Whether on an offensive or defensive position in AD/CVD cases, companies affected by the international trade of cannabis should become familiar with how these trade laws work and how these cases can be used so that they can plan accordingly. In the meantime, for more on the international cannabis trade, check out the following posts: The International Cannabis Trade: Webinar Video Replay USMCA and Cannabis Trade How to Export Medical Cannabis Internationally International Cannabis: Selling Worldwide U.S. Cannabis and International Trade: Never the Twain Shall Meet? International Cannabis: Breaking the Law, Staying Honest Should You Import Hemp to the United States? International Cannabis: Guidance for Companies Entering the U.S. Market International Cannabis Continues to Look to the U.S. Market As China’s Hemp Industry Suffers, U.S. Hemp Growers Prepare to Pounce What to Consider Before Entering the European CBD Market Border Woes: Transporting CBD into Canada is Not OK Cannabis and International Trade: Don’t Ignore the U.S.–China Trade War Will China Really Buy More U.S. Hemp? There is No Guarantee Cannabis, Tariffs and Vaping Imports from China Cannabis Legalization Roundup: Mexico, Luxembourg, Switzerland The World Trade Organization and Cannabis Check Out Our Cannabis Law Services Share Twitter Facebook LinkedIn E-mail Comment Adams Lee Adams Lee has more than twenty years’ experience providing strategic advice and legal guidance on complex international trade and administrative regulatory matters to US and foreign companies, trade associations, and foreign governments. He advises companies in a broad range of industries on international trade remedy and trade policy issues. Adams brings a wealth of knowledge to Harris Sliwoski’s international trade practice. He is adept at quickly evaluating strategic options and developing the best comprehensive legal approach in light of relevant policy and case law. Beyond achieving significant DOC and ITC results that improve his clients’ competitive position, Adams helps them understand complex trade issues so they can make well-informed business decisions. Harris Sliwoski Attorney Read more posts [email protected] Read More International Cannabis Law, Medical Marijuana, Recreational Marijuana Related Posts September 25, 2026 DEA Enforcement in a Changing Cannabis Landscape: Rescheduling, Hemp, and What Comes Next September 17, 2026 The Supreme Court May Decide if Cannabis-Related Residency Requirements are Unconstitutional September 16, 2026 A $31.8 Million Cannabis-Related Verdict That a Federal Court Wouldn’t Enforce September 15, 2026 Jason Adelstone Moderates Federal Cannabis Policy Discussion at IgniteIt Denver September 11, 2026 Medical Marijuana in Schedule III Survives Its First Major Challenge September 10, 2026 How to Acquire a Colorado Cannabis License September 4, 2026 The Intoxicating Hemp Products Ban Was Delayed a Month. Now What? August 31, 2026 Is the Global Shift to the Right Threatening International Cannabis Reforms? August 28, 2026 Oregon Cannabis Roundup: Fall 2026 August 26, 2026 Five Bills Every California Cannabis Operator Needs to Track in 2026 August 14, 2026 California Cannabis Contracts After Rescheduling: Why Your Contracts Need a Second Look August 4, 2026 DCC License Conversions After Rescheduling: How and When to Split A/M Licenses in California August 3, 2026 The Contradictions of Cannabis Law: From the United States to International Treaties July 28, 2026 What California Operators Must Do After Rescheduling: DEA Registration, License Restructuring, and 280E July 24, 2026 Medical Marijuana Schedule III Litigation: The D.C. Circuit's First Major Test Leave a comment Cancel reply